The reemergence of coronavirus prompts the need for the development of effective therapeutics to prevent the cellular entry and replication of coronavirus. This study demonstrated the putative inhibitory potential of lopinavir, remdesivir, oseltamir, azithromycin, ribavirin, and chloroquine towards V-ATPase, protein kinase A, SARS-CoV spike glycoprotein/ACE-2 complex and viral proteases. The pharmacodynamic and pharmacokinetic properties were predicted through the pkCSM server while the corresponding binding affinity of the selected drugs towards the proteins was computed using AutodockVina Screening tool. The ADMET properties revealed all the drugs possess drug-like properties. Lopinavir has the highest binding affinities to the pocket site of SARS-CoV spike glycoprotein/ACE-2 complex, cyclic AMP-dependent protein kinase A and 3-Chymotrypsin like protease while redemsivir has the highest binding affinities for vacuolar proton-translocating ATPase (V-ATPase) and papain-like proteins. The amino acids Asp269, Leu370, His374, and His345 were predicted as the key residues for lopinavir binding to human SARS-CoV spike glycoprotein/ACE-2 complex while His378, Tyr515, Leu73, Leu100, Phe32 and Phe40 for remdesivir and Tyr510, Phe504, Met62, Tyr50, and His378 were predicted for azithromycin as the key residues for binding to SARS-CoV spike glycoprotein/ACE-2 complex. Moreover, it was also observed that chloroquine has appreciable binding affinities for 3-Chymotrpsin- like protease and cyclic AMP-dependent protein kinase A when compared to Oseltamivir and ribavirin. The study provided evidence suggesting putative repurposing of the selected drugs for the development of valuable drugs for the prevention of cellular entry and replication of coronavirus.
Phytochemical analysis involves both qualitative and quantitative analysis. While qualitative analysis is concerned with the presence or absence of a phytochemical, quantitative analysis accounts for the quantity or the concentration of the phytochemical present in the plant sample. The first step in phytochemical analysis is preliminary phytochemical screening before quantitative analysis. Quantitative analysis is a more comprehensive and useful method compared to qualitative analysis because the results obtained from the studies can be useful for drug discovery, standardization of herbal drugs, explanation of the medicinal potentials of plants and determination of the toxicity levels in plants. This chapter details the various simplified methods for the qualitative 382and quantitative analysis of phytochemicals including proximate composition analysis. It also presents useful hints for reagent preparation, how to determine the concentration of plant extract and make dilute solutions for standard curve making. It also details how to calculate the half maximal inhibitory concentration (IC50) of plant extracts on a given biological system among other calculations commonly encountered during phytochemical studies.
31 January 2020 in DARU Journal of Pharmaceutical Sciences